In a stunning display of budgetary sleight of hand, the Trump administration claims it will save tens of billions on Medicaid by negotiating drug prices, all while providing precious little information on just what those deals entail.
Over 50 bipartisan lawmakers are urging the Trump administration to reconsider a proposed Medicare policy, asserting it could hinder innovation in cancer treatment and patient acc…
President Trump is poised to announce that all 50 states will participate in a Medicaid program aimed at lowering drug prices through most favored nation pricing, stirring debate…
President Trump has announced a new Medicaid program aimed at lowering drug prices by aligning U.S. costs with those of other countries. The initiative, however, raises questions…
As CBS's iconic news program '60 Minutes' gears up for its next season, it faces a unique challenge of integrating pharmaceutical sponsorships into its traditionally hard-hitting…
President Trump has announced a groundbreaking initiative to align U.S. prescription drug prices with the lowest rates found in other developed nations, promising to save American…
In a bold move that could shake the foundations of pharmaceutical pricing, Colorado's attempt to cap drug prices faces the wrath of Amgen and a federal court. As the battle for af…
As international drug companies ramp up their demands for higher prices, Australia faces a looming crisis in access to essential medications, leading to a farcical standoff that p…